ANDEXXA Phase IV Trial Stopped Early After Achieving Pre-specified Criteria on Hemostatic Efficacy Versus Usual Care
AstraZeneca to proceed with regulatory filings to convert from conditional to full approval in the US and EU ... | June 5, 2023
Stay updated with breaking news from Novel Methods. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AstraZeneca to proceed with regulatory filings to convert from conditional to full approval in the US and EU ... | June 5, 2023
Of the immense volume of valuable information offered and exchanged during the first day of the American College of Cardiology's Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC, the DAIC editorial team has selected a sampling of session highlights from our notebooks of top ACC.23/WCC news.
/PRNewswire/ -- Conformal Medical, Inc. announced today the results from the CONFORMAL Early Feasibility Study (EFS), evaluating the use of angiography...
/PRNewswire/ -- Conformal Medical, Inc. announced today the presentation of the one-year data from the company's initial left atrial appendage occlusion (LAAO)...
/PRNewswire/ -- Conformal Medical, Inc., a medical device company developing next-generation left atrial appendage occlusion (LAAO) technology, today announced...